Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice.
Haga, Hidaka
Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice. [electronic resource] - Pharmacology, biochemistry, and behavior 04 2020 - 172891 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-5177
10.1016/j.pbb.2020.172891 doi
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine--adverse effects
Animals
Antiparkinson Agents--administration & dosage
Blood-Brain Barrier--drug effects
Cell Death--drug effects
Cognitive Dysfunction--drug therapy
Disease Models, Animal
Dopaminergic Neurons--drug effects
Fatty Acid Binding Protein 3--metabolism
Levodopa--administration & dosage
Ligands
Male
Mice
Mice, Inbred C57BL
Motor Activity--drug effects
Neuroprotective Agents--administration & dosage
Parkinson Disease--drug therapy
Protein Aggregation, Pathological--drug therapy
alpha-Synuclein--metabolism
Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice. [electronic resource] - Pharmacology, biochemistry, and behavior 04 2020 - 172891 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-5177
10.1016/j.pbb.2020.172891 doi
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine--adverse effects
Animals
Antiparkinson Agents--administration & dosage
Blood-Brain Barrier--drug effects
Cell Death--drug effects
Cognitive Dysfunction--drug therapy
Disease Models, Animal
Dopaminergic Neurons--drug effects
Fatty Acid Binding Protein 3--metabolism
Levodopa--administration & dosage
Ligands
Male
Mice
Mice, Inbred C57BL
Motor Activity--drug effects
Neuroprotective Agents--administration & dosage
Parkinson Disease--drug therapy
Protein Aggregation, Pathological--drug therapy
alpha-Synuclein--metabolism